drugset / Trial / NCT01771666

Pilot Indocyanine Green Imaging for Mapping of Arm Draining Lymphatics & Nodes in Breast Cancer

NCT01771666

Phase 2 Completed 23 enrolled Stanford University
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to determine if Indocyanine Green (IC-GREEN) is comparable to isosulfan blue (IS-BLUE) in the identification of arm lymphatics and arm-draining nodes during nodal staging procedures in breast cancer.

Timeline

Start
2012-07
Primary completion
2015-03-17
Completion
2015-03-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent 1 mg/ml
Subject isosulfan blue Diagnostic / imaging agent 3 ml
Subject isosulfan blue Diagnostic / imaging agent 5 ml
Background 99technetium-sulfur colloid radiolabel Diagnostic / imaging agent

Indications